Avanos Medical (AVNS) Intangibles (2013 - 2026)

Avanos Medical has disclosed Intangibles across 14 years of filings, most recently posting $114.7 million for Q1 2026.

• In Q1 2026, Intangibles rose 7.0% year-over-year to $114.7 million; the TTM figure through Mar 2026 stood at $114.7 million (up 7.0% YoY), while the FY2025 annual figure was $117.8 million, up 4.9% from the prior year.
• Intangibles came in at $114.7 million for Q1 2026 at Avanos Medical, down from $117.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $271.1 million in Q1 2022 to a low of $105.4 million in Q2 2025.
• Average Intangibles over 5 years is $196.3 million, with a median of $226.2 million recorded in 2024.
• Year-over-year, Intangibles soared 78.05% in 2022 and sank 53.95% in 2025.
• Over 5 years, Intangibles stood at $234.2 million in 2022, then climbed by 2.26% to $239.5 million in 2023, then plunged by 53.11% to $112.3 million in 2024, then climbed by 4.9% to $117.8 million in 2025, then dropped by 2.63% to $114.7 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $114.7 million in Q1 2026, $117.8 million in Q4 2025, and $122.0 million in Q3 2025.